Array Biopharma Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ARRAY BIOPHARMA INC, and when can generic versions of ARRAY BIOPHARMA INC drugs launch?
ARRAY BIOPHARMA INC has two approved drugs.
There are seventeen US patents protecting ARRAY BIOPHARMA INC drugs.
There are three hundred and seven patent family members on ARRAY BIOPHARMA INC drugs in fifty-seven countries and forty-five supplementary protection certificates in nineteen countries.
Summary for Array Biopharma Inc
International Patents: | 307 |
US Patents: | 17 |
Tradenames: | 2 |
Ingredients: | 2 |
NDAs: | 2 |
Drugs and US Patents for Array Biopharma Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Array Biopharma Inc | BRAFTOVI | encorafenib | CAPSULE;ORAL | 210496-001 | Jun 27, 2018 | DISCN | Yes | No | 10,005,761 | ⤷ Sign Up | ⤷ Sign Up | ||||
Array Biopharma Inc | BRAFTOVI | encorafenib | CAPSULE;ORAL | 210496-002 | Jun 27, 2018 | RX | Yes | Yes | 9,593,100 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Array Biopharma Inc | BRAFTOVI | encorafenib | CAPSULE;ORAL | 210496-001 | Jun 27, 2018 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Array Biopharma Inc | BRAFTOVI | encorafenib | CAPSULE;ORAL | 210496-001 | Jun 27, 2018 | DISCN | Yes | No | 9,593,099 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Array Biopharma Inc | BRAFTOVI | encorafenib | CAPSULE;ORAL | 210496-001 | Jun 27, 2018 | DISCN | Yes | No | 9,387,208 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Array Biopharma Inc | BRAFTOVI | encorafenib | CAPSULE;ORAL | 210496-002 | Jun 27, 2018 | RX | Yes | Yes | 9,474,754 | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Array Biopharma Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Array Biopharma Inc | MEKTOVI | binimetinib | TABLET;ORAL | 210498-001 | Jun 27, 2018 | 8,178,693 | ⤷ Sign Up |
Array Biopharma Inc | MEKTOVI | binimetinib | TABLET;ORAL | 210498-001 | Jun 27, 2018 | 8,513,293 | ⤷ Sign Up |
Array Biopharma Inc | MEKTOVI | binimetinib | TABLET;ORAL | 210498-001 | Jun 27, 2018 | 8,193,229 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Array Biopharma Inc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Spain | 2635666 | ⤷ Sign Up |
Chile | 2012002380 | ⤷ Sign Up |
Brazil | 112012004453 | ⤷ Sign Up |
Iceland | 8384 | ⤷ Sign Up |
Hong Kong | 1204976 | ⤷ Sign Up |
South Korea | 100984595 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Array Biopharma Inc Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2727918 | 300975 | Netherlands | ⤷ Sign Up | PRODUCT NAME: COMBINATIE VAN BINIMETINIB EN ENCORAFENIB, BEIDE IN ALLE VORMEN ZOALS BESCHERMD DOOR HET BASISOCTROOI; REGISTRATION NO/DATE: EU/1/18/1314 20180924 |
2470526 | C201930019 | Spain | ⤷ Sign Up | PRODUCT NAME: ENCORAFENIB O UNA SAL O UN SOLVATO FARMACEUTICAMENTE ACEPTABLE DEL MISMO; NATIONAL AUTHORISATION NUMBER: EU/1/18/1314; DATE OF AUTHORISATION: 20180920; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/18/1314; DATE OF FIRST AUTHORISATION IN EEA: 20180920 |
1482932 | 132019000000043 | Italy | ⤷ Sign Up | PRODUCT NAME: BINIMETINIB IN TUTTE LE FORME PROTETTE DAL BREVETTO DI BASE(MEKTOVI); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/18/1315, 20180924 |
2727918 | 122019000023 | Germany | ⤷ Sign Up | |
2470526 | 2019C/508 | Belgium | ⤷ Sign Up | DETAILS ASSIGNMENT: CHANGE OF OWNER(S), MERGE |
2727918 | LUC00102 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: BRAFTOVI - ENCORAFENIB; MEKTOVI - BINIMETINIB; AUTHORISATION NUMBER AND DATE: EU/1/18/1314 20180924 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.